María Esther Gil-Alegre

Poly-ε-caprolactone microspheres as a drug delivery system for cannabinoid administration: Development, characterization and in vitro evaluation of their antitumoral efficacy

Dolores Hernán Pérez de la Ossa, Alessia Ligresti, María Esther Gil-Alegre et al. · Journal of Controlled Release · 2012 · 114 citations

Pharmacy, Pharmaceutics, Pharmacology +17

Local Delivery of Cannabinoid-Loaded Microparticles Inhibits Tumor Growth in a Murine Xenograft Model of Glioblastoma Multiforme

Dolores Hernán Pérez de la Ossa, Mar Lorente, María Esther Gil-Alegre et al. · PLoS ONE · 2013 · 103 citations · Full text

Pharmacy, Oncology, Pharmacology +16

Exploiting Nanotechnologies and TRPV1 Channels to Investigate the Putative Anandamide Membrane Transporter

Alessia Ligresti, Luciano De Petrocellis, Dolores Hernán Pérez de la Ossa et al. · PLoS ONE · 2010 · 37 citations · Full text

Medicine, Biochemistry, Pharmacology +17

Selection of PLA polymers for the development of injectable prilocaine controlled release microparticles: Usefulness of thermal analysis

Marco Bragagni, Cristina Beneitez, Cristina Muñoz‐San Martín et al. · International Journal of Pharmaceutics · 2012 · 32 citations · Full text

Pharmacy, Pharmaceutics, Pharmacokinetics +17

Improving the therapeutic efficacy of prilocaine by PLGA microparticles: Preparation, characterization and in vivo evaluation

Marco Bragagni, María Esther Gil-Alegre, P. Mura et al. · International Journal of Pharmaceutics · 2018 · 26 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +15